Health In Tech, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$8M
↑+53.1% +$3Mvs FY2024 (Q4)
Gross Profit
$4M
↑+8.7% +$331Kvs FY2024 (Q4)
Operating Income
$4M
↑+15.8% +$477Kvs FY2024 (Q4)
Net Income
$4M
↑+17.1% +$511Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $8M | $5M |
| COGS | $3M | $1M |
| Gross Profit | $4M | $4M |
| R&D | $213K | $634K |
| SG&A | $0 | $0 |
| D&A | $411K | $136K |
| Other OpEx | $0 | $0 |
| Operating Income | $4M | $3M |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $4M | $3M |
| Tax | $0 | $33K |
| Net Income | $4M | $3M |
QuarterCharts · SEC EDGAR data · HIT · Comparing FY2025 (Q4) vs FY2024 (Q4)